 | • レポートコード：360iR22NB031 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、259ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の調査レポートでは、世界のテストステロン補充療法市場規模が2021年の451.33百万ドルから、2022年に483.74百万ドルに達すると予測しています。今後、2027年まで年平均7.43%で、694.02百万ドルまでに成長する見込みです。本市場調査資料では、テストステロン補充療法の世界市場を調査対象とし、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、疾患別（自己免疫疾患、遺伝性疾患、性腺機能低下症、性器手術）分析、製品種類別（バッカル剤、ジェル/クリーム、インプラント、経口、非経口、パッチ）分析、医薬品有効成分別（メチルテストステロン、シピオン酸テストステロン、テストステロンエナンテート）分析、流通チャネル別（病院薬局、オンライン薬局・小売薬局）分析、エンドユーザー別（ホームケア、病院、専門診療所）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを整理しました。本書ではAbbVie Inc、Acerus Pharmaceuticals Corp、Acrux Ltd.、Actiza Pharmaceutical Pvt. Ltd.、Antares Pharma Inc.,、Aytu BioPharma Inc.、Bausch Health Co. Inc、Bayer AG、BIOTE MEDICAL LLC、Cipla Ltd.、Clarus Therapeutics Inc.,、Eli Lilly and Co.,、Endo International Plc、Novartis AG,などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のテストステロン補充療法市場規模：疾患別 - 自己免疫疾患における市場規模 - 遺伝性疾患における市場規模 - 性腺機能低下症における市場規模 - 性器手術における市場規模 ・世界のテストステロン補充療法市場規模：製品種類別 - バッカル剤形テストステロン補充療法の市場規模 - ジェル/クリーム型テストステロン補充療法の市場規模 - インプラント型テストステロン補充療法の市場規模 - 経口型テストステロン補充療法の市場規模 - 非経口型テストステロン補充療法の市場規模 - パッチ型テストステロン補充療法の市場規模 ・世界のテストステロン補充療法市場規模：医薬品有効成分別 - メチルテストステロン補充療法の市場規模 - シピオン酸テストステロン補充療法の市場規模 - テストステロンエナンテート補充療法の市場規模 ・世界のテストステロン補充療法市場規模：流通チャネル別 - 病院薬局チャネルの市場規模 - オンライン薬局・小売薬局チャネルの市場規模 ・世界のテストステロン補充療法市場規模：エンドユーザー別 - ホームケアにおける市場規模 - 病院における市場規模 - 専門診療所における市場規模 ・世界のテストステロン補充療法市場規模：地域別 - 南北アメリカのテストステロン補充療法市場規模 アメリカのテストステロン補充療法市場規模 カナダのテストステロン補充療法市場規模 ブラジルのテストステロン補充療法市場規模 ... - アジア太平洋のテストステロン補充療法市場規模 日本のテストステロン補充療法市場規模 中国のテストステロン補充療法市場規模 インドのテストステロン補充療法市場規模 韓国のテストステロン補充療法市場規模 台湾のテストステロン補充療法市場規模 ... - ヨーロッパ/中東/アフリカのテストステロン補充療法市場規模 イギリスのテストステロン補充療法市場規模 ドイツのテストステロン補充療法市場規模 フランスのテストステロン補充療法市場規模 ロシアのテストステロン補充療法市場規模 ... - その他地域のテストステロン補充療法市場規模 ・競争状況 ・企業情報 |
The Global Testosterone Replacement Therapy Market size was estimated at USD 451.33 million in 2021 and expected to reach USD 483.74 million in 2022, and is projected to grow at a CAGR 7.43% to reach USD 694.02 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Testosterone Replacement Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Indication, the market was studied across Autoimmune Conditions, Genetic Disorders, Hypogonadism, and Sex Organ Surgeries.
Based on Product Type, the market was studied across Buccal Adhesive, Gel/Creams, Implants, Oral, Parenteral, and Patches.
Based on Drug Active Ingredient, the market was studied across Methyltestosterone, Testosterone Cypionate, and Testosterone Enanthate.
Based on Distribution Channel, the market was studied across Hospital Pharmacy and Online Pharmacy Retail Pharmacy.
Based on End-Users, the market was studied across Homecare, Hospitals, and Specialty Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Testosterone Replacement Therapy market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Testosterone Replacement Therapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Testosterone Replacement Therapy Market, including AbbVie Inc, Acerus Pharmaceuticals Corp, Acrux Ltd., Actiza Pharmaceutical Pvt. Ltd., Antares Pharma Inc.,, Aytu BioPharma Inc., Bausch Health Co. Inc, Bayer AG, BIOTE MEDICAL LLC, Cipla Ltd., Clarus Therapeutics Inc.,, Eli Lilly and Co.,, Endo International Plc, Novartis AG,, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd.,, The Simple Pharma Co. UK Ltd., Upsher Smith Laboratories LLC,, and Viatris Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Testosterone Replacement Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Testosterone Replacement Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Testosterone Replacement Therapy Market?
4. What is the competitive strategic window for opportunities in the Global Testosterone Replacement Therapy Market?
5. What are the technology trends and regulatory frameworks in the Global Testosterone Replacement Therapy Market?
6. What is the market share of the leading vendors in the Global Testosterone Replacement Therapy Market?
7. What modes and strategic moves are considered suitable for entering the Global Testosterone Replacement Therapy Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of testosterone deficiency
5.1.1.2. Rising awareness of treatment of testosterone deficiency and erectile dysfunction.
5.1.1.3. High adoption for non-medical uses such as body-building and enhancing sexual performance
5.1.2. Restraints
5.1.2.1. High cost of testosterone replacement therapy
5.1.3. Opportunities
5.1.3.1. Increased clinical research and development for novel products
5.1.3.2. Government initiatives and availability of drugs through online & offline pharmacies
5.1.4. Challenges
5.1.4.1. Complications associated with the testosterone replacement therapy
5.2. Cumulative Impact of COVID-19
6. Testosterone Replacement Therapy Market, by Indication
6.1. Introduction
6.2. Autoimmune Conditions
6.3. Genetic Disorders
6.4. Hypogonadism
6.5. Sex Organ Surgeries
7. Testosterone Replacement Therapy Market, by Product Type
7.1. Introduction
7.2. Buccal Adhesive
7.3. Gel/Creams
7.4. Implants
7.5. Oral
7.6. Parenteral
7.7. Patches
8. Testosterone Replacement Therapy Market, by Drug Active Ingredient
8.1. Introduction
8.2. Methyltestosterone
8.3. Testosterone Cypionate
8.4. Testosterone Enanthate
9. Testosterone Replacement Therapy Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy Retail Pharmacy
10. Testosterone Replacement Therapy Market, by End-Users
10.1. Introduction
10.2. Homecare
10.3. Hospitals
10.4. Specialty Clinics
11. Americas Testosterone Replacement Therapy Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Testosterone Replacement Therapy Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Testosterone Replacement Therapy Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. AbbVie Inc
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Acerus Pharmaceuticals Corp
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Acrux Ltd.
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Actiza Pharmaceutical Pvt. Ltd.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Antares Pharma Inc.,
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Aytu BioPharma Inc.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Bausch Health Co. Inc
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Bayer AG
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. BIOTE MEDICAL LLC
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Cipla Ltd.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Clarus Therapeutics Inc.,
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Eli Lilly and Co.,
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Endo International Plc
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Novartis AG,
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Pfizer Inc.
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Sun Pharmaceutical Industries Ltd.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Teva Pharmaceutical Industries Ltd.,
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. The Simple Pharma Co. UK Ltd.
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Upsher Smith Laboratories LLC,
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Viatris Inc
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing